Free Hormone Fraction and Bioavailability

Free Hormone Fraction and Bioavailability refers to the proportion of a hormone in the bloodstream that is not bound to plasma proteins and is therefore biologically active and able to interact with target cells. Most hormones circulate in the blood bound to carrier proteins, which serve to transport the hormone, extend its half-life, and regulate its access to tissues. However, only the unbound or "free" fraction of the hormone is capable of diffusing across cell membranes, binding to receptors, and eliciting physiological effects. Bioavailability in this context signifies the fraction of total hormone that is freely available to exert its biological function.

Hormone Binding to Plasma Proteins

Hormones in circulation can be bound to specific or nonspecific plasma proteins. The degree of binding varies widely among different hormones and affects their free fraction:

• Thyroid hormones (T4 and T3) are largely bound to thyroxine-binding globulin (TBG), transthyretin, and albumin.
• Steroid hormones such as testosterone and cortisol bind mainly to sex hormone-binding globulin (SHBG) and corticosteroid-binding globulin (CBG), respectively, as well as albumin.
• Peptide hormones generally circulate unbound or loosely bound.

The binding proteins serve several functions:

• Protect hormones from enzymatic degradation and renal clearance.
• Maintain a circulating reservoir of hormone.
• Modulate their free concentrations by reversible binding.

The affinity and capacity of binding proteins determine the equilibrium between bound and free hormone.

Free Hormone Fraction: Definition and Determinants

The free hormone fraction is the ratio or percentage of hormone molecules that remain unbound in plasma. It is governed by the law of mass action, where hormone molecules bind reversibly to plasma proteins depending on their concentration and binding affinity.

Mathematically, if H_total represents total hormone concentration, H_free the free hormone concentration, and P the concentration of binding protein, then the binding equilibrium can be described by:

where K_d is the dissociation constant reflecting the affinity between hormone and binding protein.

Factors influencing the free hormone fraction include:

• Variations in binding protein concentration (e.g., changes in SHBG due to sex steroids or liver disease).
• Altered binding affinity (e.g., mutations or competitive displacement by drugs or other hormones).
• Changes in total hormone concentration.

Measurement and Clinical Relevance

Direct measurement of free hormone levels is technically challenging due to their low concentrations and the dynamic equilibrium with bound hormone. Common approaches include:

• Equilibrium dialysis or ultrafiltration methods that physically separate free hormone.
• Calculated free hormone indices using total hormone and binding protein concentrations, along with known binding constants.
• Immunoassays designed to selectively detect free hormone, though these can have limitations in specificity.

Clinically, the free hormone fraction is more representative of hormonal activity than total hormone levels, particularly in conditions where binding protein levels are altered, such as:

• Pregnancy, where increased estrogen elevates SHBG.
• Liver disease reducing binding protein synthesis.
• Nephrotic syndrome causing protein loss.
• Thyroid disorders affecting TBG levels.

For example, in thyroid function assessment, free T4 and free T3 measurements reflect the bioavailable hormone better than total hormone concentrations, guiding diagnosis and treatment.

Bioavailability and Physiological Impact

Bioavailability here refers to the portion of hormone that is free and accessible to target tissues. Only free hormones can:

• Cross the capillary endothelium.
• Enter cells by passive diffusion or active transport.
• Bind intracellular or membrane receptors to initiate signaling cascades.

This free fraction determines the intensity and duration of hormonal effects. Factors influencing bioavailability also impact hormone clearance and metabolism.

Alterations in free hormone fraction can lead to:

• Clinical hypothyroidism or hyperthyroidism despite normal total hormone levels.
• Misinterpretation of androgen status when SHBG levels fluctuate.
• Changes in cortisol bioavailability affecting stress response.

Understanding free hormone fraction and bioavailability is essential for accurate diagnosis, therapeutic monitoring, and research in endocrinology.

Summary Table: Examples of Hormone Binding and Free Fractions

Interactions Affecting Free Hormone Fraction

Several physiological and pathological conditions alter the free hormone fraction by modifying binding proteins or competing ligands:

• Estrogens increase SHBG, lowering free testosterone and androgen bioavailability.
• Androgens decrease SHBG, increasing free testosterone levels.
• Drugs such as phenytoin, valproic acid, or glucocorticoids can displace hormones from binding proteins.
• Non-esterified fatty acids and bilirubin may compete for albumin binding sites.
• Genetic variants in binding proteins alter affinity and concentration.

These interactions complicate hormone assessment and require careful interpretation of free hormone measurements.

Summary

The free hormone fraction represents the biologically active portion of circulating hormones unbound to plasma proteins. Its determination is critical because it directly correlates with hormone bioavailability and physiological effect. Variations in binding protein levels, affinity, and total hormone concentration influence the free fraction and therefore the clinical interpretation of hormone status. Accurate assessment of free hormone fraction is essential for diagnosing endocrine disorders, guiding therapy, and understanding hormone action in health and disease.